An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Treatment Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before directing customers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering products of uncertain source.
Several experts stated the popularity for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate medicines, marketing, and customer laws, potentially leading to fines, legal action or prison.
Platform Response and Content Elimination
Based on TikTok, the service has taken down problematic material and banned related keywords and search suggestions. The organization stated it was dedicated to keeping the platform secure and investing in strengthening compliance measures.
Online Marketplace Activities
Investigations also discovered communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at home.
After minutes of joining one community, a seller shared contact information, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.
Item Information and Costs
Within these groups, messages show black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.
Service Oversight and Security Actions
A representative for the messaging service stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they can’t verify. Even if the science behind this drug is sound, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the increase in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has already encountered patients injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to possibly serious medical dangers”.
